Incyte Corporation (INCY)
FlaggedUS listed · Healthcare · Biotechnology
This page tracks Incyte Corporation (INCY) with live price data, technical indicators (RSI, MACD, moving averages, Sharpe ratio), and AI-powered analysis. Our scanner continuously reviews INCY against ~5,000 North American equities — fusing market fundamentals with frontier AI to surface high-conviction opportunities before they break out.
New to these indicators? RSI, MACD, and moving averages explained — plus how AI forecasting works.
Latest AI Analysis
Updated Sep 28, 2026Screen strength 2.1The pre-screen's STRONG_BUY signal is CHALLENGED to a solid BUY based on mixed technicals and macro headwinds offsetting strong fundamentals. The 0.94 Sharpe and 37.23% CAGR confirm a durable uptrend; price is above both rising SMA-50 ($123.24) and SMA-200 ($106.25), a clean bullish structure. However, the MACD histogram is negative (-0.274) with no fresh crossover, today's close sits 0.8x volume (light conviction), and the Fear & Greed Index at 34 signals broad market anxiety that could pressure even quality names. HC Wainwright's raised price target to $152 and the Atebrioz competitive win are positive catalysts, but the macro tape (elevated Treasury yields, oil prices, sector rotation away from AI concentration) creates headwinds. Confirmation should watch for MACD to turn positive and volume to sustain above 1.2x on further moves.
INCY AI Signal Track Record
Recent scanner signals for Incyte Corporation. Each is a point-in-time AI assessment, not a guarantee of future performance.
| Date | Signal | Screen strength | Price at signal |
|---|---|---|---|
| Sep 28, 2026 | Flagged | 2.1 | $125.99 |
| Sep 28, 2026 | Flagged | 2.1 | $125.53 |
| Sep 28, 2026 | Flagged | 2.1 | $124.99 |
| Sep 28, 2026 | Flagged | 2.1 | $124.55 |
| Sep 28, 2026 | Flagged | 2.1 | $124.69 |
INCY — Frequently Asked Questions
Is Incyte Corporation (INCY) a buy right now?
As of September 28, 2026, StockTracker AI's screen flags INCY as Flagged, with a ±1.7% typical 3-day move, based on its multi-factor technical screen and AI review. This is a technical screen and informational analysis, not financial advice or a recommendation to trade — confirm it against your own research and risk tolerance.
What is INCY's RSI?
INCY's 14-day RSI was 49.0 at the last scan — in neutral territory. RSI above 70 is generally considered overbought and below 30 oversold; the 40–60 band is neutral and is best read alongside trend and momentum rather than on its own.
What is the AI price forecast for INCY?
StockTracker AI generates a probability-weighted 30-day price forecast for INCY — a mathematical baseline (regression on recent prices) adjusted by an AI model for news, earnings proximity, and the current macro regime, with bull/base/bear scenarios. Sign in to generate the latest forecast.
How does StockTracker AI analyze INCY?
Each scan screens INCY on momentum, RSI, MACD, moving-average posture, Sharpe ratio, and 1-year CAGR to build a composite score, then a frontier AI model reviews the full picture — fundamentals, macro context, and recent news — to confirm or challenge the signal before it's surfaced.
Get the full picture for INCY — free.
Add INCY to a watchlist for instant scanner alerts. Run an on-demand 30-day AI price forecast. See the full historical signal track record. Free tier, no credit card.
Related stocks in Healthcare
Get scanner alerts and AI forecasts for INCY
Free tier includes daily AI analysis, charts with indicators, and a 3-stock watchlist. No credit card.
Get Started →